LOSS OF INI 1 PROTEIN EXPRESSION

Clinical trials for LOSS OF INI 1 PROTEIN EXPRESSION explained in plain language.

Never miss a new study

Get alerted when new LOSS OF INI 1 PROTEIN EXPRESSION trials appear

Sign up with your email to follow new studies for LOSS OF INI 1 PROTEIN EXPRESSION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Terminated 1

Trial tests powerful drug duo against rare, aggressive kidney cancer

Disease control Terminated

This study tested whether a combination of two immunotherapy drugs, nivolumab and ipilimumab, could help control a rare and aggressive type of kidney cancer called renal medullary carcinoma. It involved a small group of patients with advanced disease to see if the treatment could…

Matched conditions: LOSS OF INI 1 PROTEIN EXPRESSION

Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control

Last updated Mar 16, 2026 15:25 UTC

LOSS OF INI 1 PROTEIN EXPRESSION

Get alerted when new LOSS OF INI 1 PROTEIN EXPRESSION trials appear

Trial tests powerful drug duo against rare, aggressive kidney cancer